GHK-Cu (Copper Tripeptide-1)
PeptideThe medical score is lower because clinical evidence derives primarily from small studies with limited participant numbers [s4, s6], while the community reports considerably more positively based on subjectively perceived improvements in skin and hair [c1, c2, c3]. Clinical uncertainties regarding injectable forms further reduce the medical score [s7].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
GHK-Cu is the best-evidenced cosmetic peptide: multiple controlled studies show consistent improvements in skin elasticity and collagen synthesis with topical use, and community sentiment is notably positive. For injectable forms, the data is far thinner — anecdote dominates, and supplier quality issues are a genuine risk. Wilson's disease is an absolute contraindication. For topical use, allow 8–12 weeks before judging results and avoid combining with low-pH acids that destabilize the copper complex.
Description
GHK-Cu is a naturally occurring copper tripeptide with well-documented effects on collagen synthesis, wound healing, and skin regeneration; used primarily as a topical cosmetic [s1, s2].
GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is an endogenous tripeptide first isolated from human plasma albumin in 1973 by biochemist Loren Pickart [s1]. Endogenous GHK-Cu levels decline with age, from approximately 200 ng/ml at age 20 to below 80 ng/ml after age 60 [s2]. The peptide consists of three amino acids—glycine, L-histidine, and L-lysine—forming a copper(II) ion complex [s1]. This compound is a natural component of the tissue repair process and activates fibroblasts, keratinocytes, and immune cells following injury [s2]. Early research demonstrated stimulation of collagen, elastin, and glycosaminoglycans in skin as well as accelerated wound healing [s3]. More recent in vitro data show a 9-fold increase in collagen synthesis in rat models using GHK-incorporated collagen dressings [s2]. Clinical studies report improved skin parameters including wrinkle reduction, increased skin tightness, and enhanced collagen density following topical application [s4, s5]. GHK-Cu also influences gene expression on a broad scale: according to a review by Pickart and Margolina, the peptide upregulates or downregulates over 4,000 human genes—including genes involved in anti-inflammation, DNA repair, and neurotrophic factors [s1]. For hair growth, preliminary clinical data show improvements in hair density and thickness in androgenetic alopecia [s6]. Administration is primarily topical; injectable forms are used in the biohacking community but are not officially approved and are less well-documented [s7].
Legal Status (DE)
GHK-Cu (INCI: Copper Tripeptide-1) is legally usable in the EU as a cosmetic active ingredient in skincare products and is subject to EU Cosmetics Regulation (EC) No. 1223/2009 [s9]. As an injectable peptide, it is not classified as an approved medicinal product or dietary supplement in Germany; sale as a research chemical or through compounding pharmacies is possible but legally complex. The distinction between cosmetic and medicinal product is determined by state authorities in consultation with the BfArM [s10].
Mechanism of Action
GHK-Cu acts through several parallel mechanisms [s1, s2, s3]: 1. Collagen and elastin synthesis: GHK-Cu stimulates dermal fibroblasts to produce collagen types I and III, elastin, fibronectin, and glycosaminoglycans—the principal components of the extracellular matrix [s3, s5]. Significantly elevated collagen and elastin synthesis has been observed in human adult dermal fibroblasts at GHK-Cu concentrations of 0.01 to 100 nM [s5]. 2. Matrix metalloproteinase regulation: GHK-Cu promotes orderly remodeling of the extracellular matrix by regulating both the synthesis and enzymatic degradation of damaged structural proteins [s3]. This balance prevents excessive scar formation. 3. Antioxidant protection: The copper(II) complex neutralizes reactive oxygen species and protects skin cells from oxidative stress [s2]. 4. Angiogenesis and stem cell activation: GHK-Cu increases the expression of integrins and p63 in skin cells, promoting the stem cell character of keratinocytes and supporting active tissue renewal [s7]. It also stimulates new blood vessel formation, improving nutrient supply to the tissue [s6]. 5. Gene regulation: According to the review by Pickart and Margolina, GHK-Cu influences over 4,000 human genes; it upregulates repair, DNA remodeling, and anti-inflammatory genes while simultaneously downregulating genes associated with chronic inflammation and tissue damage [s1]. 6. Hair follicle effects: GHK-Cu enlarges hair follicles, reduces miniaturization (relevant in androgenetic alopecia), and improves scalp blood supply through angiogenesis [s6].
Dosing
Topische Hautpflege (Anti-Aging, Kollagenstimulation)
- Dose
- 0.5–2% GHK-Cu in serum or cream (equivalent to approx. 5–20 mg/ml)
- Frequency
- 1–2× täglich
- Route
- topisch
- Duration
- mindestens 8–12 Wochen für sichtbare Ergebnisse
- Timing
- Morning and/or evening after cleansing on dry skin
- With food
- optional
Wundheilung (topisch, klinisch)
- Dose
- GHK-incorporated dressings or 1–2% solutions
- Frequency
- nach klinischem Bedarf
- Route
- topisch
- Duration
- bis zur Wundheilung
- Timing
- under medical supervision
- With food
- optional
Haarwachstum (topisches Serum)
- Dose
- 0.5–2% GHK-Cu in hair serum or shampoo
- Frequency
- 1× täglich auf Kopfhaut
- Route
- topisch
- Duration
- 3–6 Monate
- Timing
- Massage into scalp, do not rinse out
- With food
- optional
Subkutane Injektion (Biohacking, experimentell)
- Dose
- 1–2 mg per injection (common in biohacking community, but not officially recommended)
- Frequency
- täglich oder jeden zweiten Tag
- Route
- injektion-subkutan
- Duration
- 4–8 Wochen Zyklen
- Timing
- Not standardized; medical supervision recommended
- With food
- optional
No officially established upper limit. For topical cosmetics, 2% is considered the standard maximum concentration in formulations [s9]. No validated upper limits exist for injectable use; copper toxicity risk from systemic overdose is theoretically possible [s8].
GHK-Cu should not be combined with strongly acidic products (pH < 4), as this may destabilize the copper complex. Injectable forms require sterile preparation and should only be used in medically supervised contexts [s7, s8].
Calculate reconstitution, plan dosing, look up injection technique
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Lokale Hautirritationen (Rötung, Kribbeln, Trockenheit) bei topischer Anwendung High concentrations may cause transient skin irritation; resolves upon dose reduction [s8]. Well-tolerated safety profile documented over decades [s4]. | selten | leicht |
| Allergische Hautreaktion (Ausschlag, Blasenbildung, anhaltende Rötung) Individual case reports from the community; topical hydrocortisone and dermatological evaluation recommended for persistent symptoms [s7]. | selten | moderat |
| Juckreiz und Kribbeln nach Injektion (systemisch) Community reports of pruritus and tingling approximately 30 hours post-injection; resolves spontaneously [c4]. | selten | leicht |
| Injektionsstellenreaktion (Rötung, Stechen) bei subkutaner Injektion Transient local reactions at the injection site; if reaction persists beyond 5 days, evaluate for infection [s7]. | gelegentlich | leicht |
| Theoretische Kupfer-Toxizität bei Überdosierung (systemisch) Topically absorbed copper amounts are minimal and present no systemic toxicity risk [s8]. Theoretically possible with abusive high-dose injectable administration; no clinical case reports known. | theoretisch | schwer |
Contraindications
Copper as a central component of the peptide complex may cause systemic or local allergic reactions in individuals with copper allergy [s2].
In impaired copper metabolism, additional copper intake can worsen hepatic and neurological toxicity; topical absorption is minimal, injectable use is contraindicated [s2].
Application to infected wounds should be performed under medical supervision; independent self-treatment is not appropriate [s2].
No safety data available for systemic/injectable use during pregnancy and lactation; topical cosmetics are considered presumably safe due to minimal absorption [s8].
Interactions
Synergistic
The combination of GHK-Cu and retinol can synergistically promote collagen synthesis and skin regeneration; GHK-Cu potentially mitigates retinol-induced irritation.
Combined application showed additive improvements in skin hydration and elasticity in clinical studies [s4].
Both substances stimulate collagen synthesis; the combination can act synergistically, however they should be applied at different times since ascorbic acid can destabilize the copper complex at very low pH.
GHK-Cu and BPC-157 act synergistically in tissue repair, collagen synthesis, and angiogenesis. Preclinical models show additive effects in wound healing and regeneration of various tissue types.
The combination of GHK-Cu and TB-500 shows potential synergistic effects on tissue repair and recovery in research models. TB-500 accelerates tissue regeneration, while GHK-Cu provides skin and connective tissue support.
GHK-Cu and KPV can be combined, with KPV providing anti-inflammatory activity and GHK-Cu promoting structural tissue regeneration. This combination may support the healing process holistically.
Caution
Acidic environment may destabilize the copper(II) complex and reduce efficacy; administer at staggered times.
Combined oral and injectable GHK-Cu administration could theoretically lead to increased systemic copper load; caution in patients with impaired copper homeostasis.
High zinc doses can inhibit copper absorption, as both minerals compete for the same intestinal transport pathway. Oral GHK-Cu preparations should be taken at a staggered time relative to high-dose zinc supplements.
Studies
Tier A — High Evidence
Outcome: Collagen density, wrinkle reduction, and skin firmness following topical GHK-Cu application
Effect Size: Significant improvement in collagen density; skin firmness +20–30% vs. placebo
Outcome: Hair count, hair diameter, and scalp coverage in androgenetic alopecia
Effect Size: 22% improvement in hair count; no adverse events reported
Tier B — Moderate Evidence
Outcome: Mechanisms of action of GHK-Cu: collagen, elastin, wound healing, gene expression
Effect Size: 9-fold increase in collagen synthesis in rat models using GHK-incorporated dressings
Outcome: Collagen and elastin synthesis following GHK-Cu incubation (0.01–100 nM)
Effect Size: Significant increase at all tested concentrations
Outcome: Gene expression regulation by GHK-Cu: >4,000 genes affected
Effect Size: Broad upregulation of reparative and anti-inflammatory genes
Tier C — Low Evidence
Outcome: Structure-activity relationships of copper peptides in cosmetic formulations
Effect Size: Qualitative description; no quantified effect sizes
Community Evidence
Top reported benefits
- Improved skin texture and elasticity after 5–8 weeks of topical application
- Smoother, more even skin appearance
- Reduced hair shedding with topical scalp application
- Improvement in skin tone and fine lines
- With injections: faster results for skin and hair reported
Top reported issues
- Quality issues with unverified suppliers (incomplete dissolution, contamination)
- Occasional allergic reactions (pruritus, erythema) post-injection
- Onset of effect is slow; no immediate results
- Concerns regarding safety and sterility of injectable forms
Several users report product quality issues with unvetted suppliers [c4, c5]. Individual voices warn of systemic risks with injectable forms, particularly in individuals with a genetic predisposition to unwanted peptide cascade effects [c4]. Community data for injectable GHK-Cu are considerably thinner than for topical application, and the biohacking context introduces additional self-medication risks.
Scientific Sources
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart L, Margolina A (2018). BioMed Research InternationalBPMID:29785218DOI - BVL – Nahrungsergänzungsmittel: Abgrenzung Lebensmittel/Arzneimittel
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) (2024). BVL.bund.deALink - Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Vasquez-Soltero JM, Margolina A (2018). International Journal of Molecular SciencesBPMID:30096966DOI - Skin Regenerative and Anti-Cancer Actions of Copper Peptides
Pickart L, Margolina A (2018). Cosmetics (MDPI)BDOI - Epigenetic mechanisms activated by GHK-Cu increase skin collagen density in clinical trial
Dymek A, Nowicka D, Rotsztejn H (2023). EurekAlert / Journal of Cosmetic Dermatology (press release referencing peer-reviewed study)ALink - Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
Badenhorst T, Bhalerao A, Davis K, et al. (2024). Medical Science MonitorALink - GHK Peptide Hair Growth Clinical Trial 2016 — Research Summary
Hairgenetix Editorial, citing Rinaldi S et al. (2016). Hairgenetix (summary of peer-reviewed clinical study)BLink - GHK-Cu Side Effects & Safety (2026 Guide)
Peptidesinsider Editorial Team (2026). Peptidesinsider.comCLink - GHK-Cu 100mg Dosage Protocol
PeptideDosages Editorial Team (2025). PeptideDosages.comCLink - Copper peptides in cosmetics – structure, effects, and regulations
Cosmacon Editorial Team (2023). Cosmacon GmbHBLink
Community Sources
Storage
Unopened
Lyophilized powder: store cool (2–8 °C) and protected from light; alternatively at −20 °C for long-term storage.
Opened
Reconstituted solution: stable for a maximum of 2–4 weeks at 2–8 °C; do not freeze after reconstitution. Topical products: store at room temperature, protected from heat and light.
Notes
GHK-Cu solutions exhibit accelerated degradation upon exposure to daylight and heat. The blue color of the copper complex is a quality indicator; discoloration indicates degradation [s7].